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The available passive mode of periodontal infections in mice requires high efficiency of bacterial attachment and invasiveness
and is not always suitable to test the pathogenicity of genetically engineered mutant strains. We developed an active mode of oral
infection, using microinjection in the marginal gingiva of mice, to test the pathogenicity of a genetically engineered Treponema
denticola mutant strain deficient in intermediate-like filaments, compared to the wild-type strain. This targeted mode of infection
inoculates the bacterial strain to be tested directly at a lesion site (needle entry point) located at the future periodontal lesion site.
The efficiency of T. denticola wild-type strain to elicit bone loss contrasted with the lack of pathogenicity of the intermediate-like
filament deficient mutant strain in comparison to the sham infection. The periodontal microinjection oral model in mice can be
used for a variety of applications complementary to the passive mode of periodontal infection in context of pathogenicity testing.
1. Introduction
Progress in microbial oral diseases research has been im-
paired by the minimal amount of information available
for most of the oral organisms and the limited availability
of tools to study those organisms. In the context of over
600 common oral organisms associated with the human
host from 13 phyla [1], only a few organisms have been
investigated. With the unprecedented effort of the Human
Microbiome Project both novel strains and genomic data
are becoming available to the public [2–4]. While genetic
tools are becoming available for a subset of organisms
[5, 6], relevant animal models are still needed to study
pathogenicity in vivo with the availability of engineered
mutant strains [5, 7–10].
Evaluating the pathogenesis of oral bacteria in animal
model is a complex issue due to the multistep process
involved. The bacteria arrive in the oral cavity associated with
a solid (food for example) or a liquid (water for example)
and have only a brief period in the oral cavity before entering
the gastrointestinal tract. During that period, the bacteria
have to “attach” to an oral surface that is comprised of
covering cells (i.e., gingival, mucosal, or other host cells),
a solid surface (tooth enamel or cementum), or other
bacterial cells from the oral biofilms with which the bacteria
can aggregate with [11]. This colonization step is also
associated with population installation through cell division
and competition with the present members of the oral flora,
under the immunological pressure of the host.
Two clinically relevant oral infections models are avail-
able in mice. The endodontic infection model provides a
mono- or polyinfection model in absence of the oral biofilm
competitors [12, 13]. This is an active mode of infection as a
lesion is created to inoculated the bacteria [13]. The passive
periodontal model of infection is based on the delivery of
the bacteria within a liquid or a gel containing the bacteria
[14, 15]. During the feeding, the bacteria adhere to an oral
surface, compete with the oral microbiota, and are subject to
host defenses.
Studying engineered bacterial mutant strains in oral
infection, including periodontitis, presents new challenges.
While the mutation is targeted, the effect of such a mutation
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may be pleiotropic at the phenotype level when considering
pathogenicity. Targeting specific component of a pathway
may also alter the bacteria ability to colonize the gingiva.
Competitiveness is a crucial element within a biofilm
from colonization to population expansion. Are motility,
attachment, and cell division rate critical factors when that
particular bacterium is part of the biofilm?
We propose an oral animal model using microinjection
of bacteria in the gingival tissue. This mouse model allows
to by-pass the initial flow, associated with ingestion, during
which attachment each cell to tissue by providing a bacterial
population in-situ at a site of lesion, which is the needle
penetration site.
2. Material and Methods
This study was conducted in compliance with the approved
animal protocol by the Institutional Animal Care and Use
Committee at The Forsyth Institute (Animal Assurance
Number A 3051-A1).
2.1. Bacterial Strains and Culture Method. Treponema denti-
cola ATCC 33520 wild-type strain and the cfpA-interrupted
mutant XC026 strain [7] were grown in New Oral Spirochete
medium (NOS) with 10% heat-inactivated rabbit serum and
10 µg of cocarboxylase per mL at 36◦C in an anaerobic
chamber (Coy Laboratory Products Inc., Grass Lake, MI)
under an atmosphere of 85% nitrogen, 10% carbon dioxide,
and 5% hydrogen [7]. Prior to inoculation, mid-log phase
liquid cultures were spun down in the anaerobic chamber.
Cell pellets were resuspended in anaerobic media. The cells
were counted using a Petroff-Hausser slide following the
manufacturer’s protocol. Cells were maintained at 36◦C
under anaerobic condition, until injection.
2.2. Animals. C57BL/6J male mice were purchased from
the Jackson Laboratory (Bar Harbor, ME, USA). The mice
were maintained under pathogen-free conditions. Five age-
matched animals (age of 7 to 9 weeks) were used in this
study per infection group. All animals received a powder diet
immediately after weaning (from the age of 3 weeks) until
being euthanized to avoid unreasonable alveolar bone loss
induced by food impaction in between molars.
2.3. Intragingival Delivery of T. denticola. All animals re-
ceived antibiotic treatment (Sulfatrim suspension, 10mL/
100mL of drinking water) for 4 days to reduce the original
oral flora, followed by 3 days of an antibiotic-free period,
prior to infection with T. denticola. On day 0, animals were
anesthetized with 62.5mg/kg ketamine HCl and 12.5mg/kg
xylazine in sterile PBS by intraperitoneal injection. After
anesthesia, the mouse was mounted on a jaw retraction
board to allow access to the oral cavity and the gingiva.
A suspension of T. denticola (109 cells/mL) was directly
delivered into palatal interproximal papillae (1 µL/site in 3
sites) of the maxilla. A surgical microscope enabled proper
injection, with a 33G needle, in the marginal gingiva along
the teeth without affecting the epithelial junction.
2.4. Measurement of Alveolar Bone Loss. Animals were eutha-
nized by CO2 inhalation on day 49 relative to infection. Max-
illae were removed and hemisected. Hemisected maxillae
were defleshed in a dermestid beetle colony [16], bleached,
and mounted on a microscope slide for bone loss mea-
surements. Palatal images of molar teeth and alveolar bone
were captured using digital microscopy (Pixera Professional
camera; Pixera, San Jose, CA). The measured polygonal area
enclosed the cemento-enamel junction, the lateral margins of
the exposed tooth roots, and the alveolar ridge. Themeasure-
ments were performed using ImageJ [17], and calibration
was performed using the image of a calibration standard at
the same magnification (Edmund Optics, Barrington, NJ,
USA). The alveolar bone loss was quantitated in a blinded
manner. Results were expressed in mm2.
2.5. Statistical Method. Bone resorption (alveolar bone loss)
measures on the left and right hemimandibles were averaged
for each animal. Mean bone resorption was then computed
for the five animals in each group. Mean levels in the three
experimental groups were evaluated by one-way analysis
of variance followed with pairwise comparisons by Tukey’s
multiple comparison procedure with overall type I error =
0.05.
3. Results and Discussion
Microbial invasion and persistence in the oral cavity are a
complex phenomenon. The newly implanted population is
subject to a permanent immunological and mechanical chal-
lenge as well as a bacterial challenge form the environment
and the food. In our experimental conditions, the bacterial
challenge is limited to the coprophagic nature of the mice;
water, food, and caging being sterilized.
We have designed an active mode of marginal gingival
infection allowing the testing of bacterial colonization at a
site of injury. This infection site is in the gingival tissue
affected by periodontal infection. The microinjection in
the marginal gingiva is performed at higher dose than a
passive infection, in only one application in contrast to
other methods [14, 15]. This methodology is advantageous
when studying genetically engineered mutant strains, where
pathogenicity might be affected, and the step of in vivo infec-
tion alteration is unknown and might include attachment
capabilities that are required to colonize the gingiva.
T. denticola wild type and the cfpA genetically engineered
derived mutant strains were used to test the model of
infection [7]. T. denticola is involved in the progression of
periodontitis [18] and is known to be an invasive bacteria
[19]. The cfpA mutant strain is deficient in intermediate-
like cytoplasmic filaments, which are associated with cell
division. The characteristic phenotypes are chromosome
condensation and filamentation [7]. Another associated
phenotype is a reduction in cell attachment [20]. Based on in
vitro characterization, this mutant strain was hypothesized
to be nonpathogenic. A passive model of infection would be
inefficient to test the pathogenicity of themutant strain, since
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Figure 1: Bone resorption measured in wild-type mice infected by
microinjection with T. denticola wild type, cfpA mutant strain, or
the resuspending media (sham).
it focuses on the ability of a strain to attach as a first step of
colonization.
Gingival microinjection of T. denticola induced sig-
nificant periodontal bone loss (Figure 1), the measured
quantitative outcome of gingival infection and periodontal
inflammation [15, 21]. In contrast, the cfpA mutant infected
mice display a bone loss similar to the sham infection. The
ANOVA procedure showed significant statistical difference
between the three groups (P = 0.0056). The lack of infec-
tivity of the cfpA mutant is underlined by the pairwise tests
(Tukey procedure) indicating a significantly higher bone
loss in wild-type mice related to the sham and T. denticola
cfpA mutant groups. The drastic loss of infectivity might
be originating from a lower fitness associated with the
chromosome condensation as observed in vitro [7].
Microinjection of wild-type and mutant strains or of
bacteria that are known to sequentially coaggregate might
circumvent the limitation of the passive modes of oral
infection. The importance of the ultrastructure formed by
the treponemal cytoplasmic filaments has been underscored
both in vitro [7, 20, 22, 23] and presently in vivo. Their
critical presence of intermediate-like filaments for T. denti-
cola pathogenicity, their continuous length [22], and their
single protein composition [24, 25] make them a candidate
for drug-target development.
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